Ketamine Assisted Psychotherapy for Opioid Use Disorder

Description

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Conditions

Opioid-use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Condition
Opioid-use Disorder
Intervention / Treatment

-

Contacts and Locations

Salt Lake City

Center on Mindfulness and Integrative Health Intervention Development, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosis of Opioid Use Disorder
  • 2. Receiving OUD treatment with a buprenorphine formulation
  • 1. Previous experience with a mindfulness-based intervention program
  • 2. Pregnancy
  • 3. Any serious medical, mental, or cognitive issue that prevents successful participation in a mindfulness-based group treatment program
  • 4. Prior use of ketamine other than as prescribed by a physician
  • 5. Any of the following medical conditions

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Utah,

Eric L Garland, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

2024-05-30